跳至主要内容
临床试验/ITMCTR2000003469
ITMCTR2000003469尚未招募4 期

A randomized double-blind controlled study for the clinical efficacy of the Tibetan medicine 'Fifteen Weisaierdou Pills'

Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd.0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 70(—)
性别
All

入选标准

  • (1) Consensus Opinions on Medical Diagnosis and Treatment of Chronic Cholecystitis and Cholecystolithiasis in China (2018) diagnostic criteria of Chronic Cholecystitis;
  • (2) It meets the diagnostic criteria of Tibetan medicine and is hot, with more than 5 clinical symptoms;
  • (3) The age range is 20-70 years old;
  • (4) Those who voluntarily participated in the research and signed the informed consent.

排除标准

  • (1) Exclude patients with acute non-calculous cholecystitis, gallbladder polyps, gallbladder cancer, gastric ulcers, gastric erosion, etc. with severe stomach disease;
  • (2) Combined with other diseases, such as severe heart, brain, kidney, lung dysfunction and trauma;
  • (3) Pregnant women and lactating women.
  • (4) Have not taken other Chinese and Western medicines for treating cholecystitis within 15 days, such as Xiaoyanlidan tablets;
  • (5) Circumstances that other researchers think are not suitable for participating in the research.

研究者

发起方
Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd.

相似试验